This measure identifies patients undergoing percutaneous coronary intervention (PCI) with placement of a drug-eluting intracoronary stent during the first 9 months of the measurement year, who filled a prescription for clopidogrel in the 3 months following stent placement.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patients in the denominator who filled prescription(s) for clopidogrel in the 3 months following placement of the drug-eluting intracoronary stent. ("Evidence suggests clopidogrel should be continued upwards of 1 year.")
Time Window: 3 months after stent placement
-
1.15 Denominator
Patients who underwent PCI with placement of a drug-eluting intracoronary stent, during the first 9 months of the measurement year, excluding those with contraindications to clopidogrel
-
Exclusions
contraindications to clopidogrel
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Cardiovascular Project 2013-2014Initial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-